CEO

Dr. Robin Donaldson is a computer scientist and entrepreneur with a PhD in simulating biological systems using Artificial Intelligence. He holds a Master’s degree from the University of Cambridge and a postdoc from Stanford University. Robin has authored 18 scientific publications with over 800 citations and holds three pending patents in AI [Patent 1, Patent 2, Patent 3]. He previously founded Ecree, an AI-powered writing solution, acquired by Newsela in 2022. After personally overcoming a severe fear of flying through the Integrated Change System, Robin was inspired to scale phobia relief to millions of people, leading to the creation of Aphobic. He now drives the company’s vision, product development, and technical strategy.

Chief Therapy Officer

Christopher Paul Jones is a globally recognized expert in fear and phobia relief, known as “The Breakthrough Expert.” He developed the Integrated Change System, a multi-modal therapeutic framework that combines techniques such as CBT, EMDR, NLP, EFT, Hypnotherapy, and others. With over 20 years of experience as a therapist, speaker, and coach, he has helped thousands overcome phobias, including Robin, inspiring the founding of Aphobic. Christopher is the author of three books, Face Your Fears, Face Your Fear of Flying and Face Your Fear of Public Speaking, and regularly appears in major media including the BBC.

Chief Commercial Officer

Geoffrey Doyle brings more than two decades of experience in global health-tech strategy, startup development, and investment. With a strong track record in commercializing medical and AI-driven technologies (particularly in orthopedics and digital health), he leads Aphobic’s growth, strategic partnerships, and go-to-market execution. Geoffrey recognized the urgent need for scalable mental health solutions and joined Robin and Chris to found Aphobic, uniting his commercial leadership with their technological and therapeutic expertise to expand access to effective phobia relief worldwide.